WOKRISE D3 TAB

Distributor inventory | Tablet

Treatment and prevention of vitamin D deficiency, vitamin D insufficiency, osteomalacia and rickets, adjunct in osteoporosis management, support for calcium absorption and bone health

Cholecalciferol is converted in the body to active vitamin D (calcitriol). It increases intestinal absorption of calcium and phosphate and supports bone mineralisation, helping correct vitamin D deficiency.

Tablet/oral use as prescribed by a doctor. Commonly taken once weekly or as directed; can be taken with or after food (preferably with a meal containing fat) to improve absorption. Swallow with water; do not exceed recommended dose.

Nausea, vomiting, constipation, abdominal pain, loss of appetite, headache, weakness, increased thirst, increased urination

Use with caution in kidney disease, history of kidney stones, hypercalcaemia, hypervitaminosis D, sarcoidosis or other granulomatous disorders. Excess dosing may cause hypercalcaemia with symptoms like confusion, severe nausea/vomiting, muscle weakness or irregular heartbeat—seek medical help. Monitor calcium, phosphate and renal function if on high-dose/long-term therapy.

Thiazide diuretics (risk of hypercalcaemia), digoxin/other cardiac glycosides (arrhythmia risk with high calcium), antiepileptics like phenytoin/carbamazepine and rifampicin (reduced vitamin D effect), corticosteroids (reduced vitamin D effect), cholestyramine/orlistat (reduced absorption), aluminium/magnesium antacids in renal impairment (toxicity risk), calcium supplements (additive hypercalcaemia risk)

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Uprise D3 60000 IU Tablet, Calcirol 60000 IU Tablet, D-Rise 60000 IU Tablet, Tayo 60K Tablet, D3 Must 60000 IU Tablet